|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.06 USD | -0.79% |
|
-5.45% | -50.59% |
| 07-22 | Keros Therapeutics, Inc. Announces CFO Changes | CI |
| 07-22 | Keros Therapeutics, Inc. Announces Appointment of Annita Tanini as Interim Principal Accounting Officer, Effective August 4, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 201M | - | - | - | ||
| 56.67B | |||||
| 55.92B | |||||
| 23.28B | - | ||||
| 23.28B | - | ||||
| 20.54B |
Select your edition
All financial news and data tailored to specific country editions
